188 related articles for article (PubMed ID: 32946982)
1. Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
Jacobs S; Ausema A; Zwart E; Weersing E; de Haan G; Bystrykh LV; Belderbos ME
Exp Hematol; 2020 Nov; 91():46-54. PubMed ID: 32946982
[TBL] [Abstract][Full Text] [Related]
2. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
[TBL] [Abstract][Full Text] [Related]
3. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
4. Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies.
Liem NL; Papa RA; Milross CG; Schmid MA; Tajbakhsh M; Choi S; Ramirez CD; Rice AM; Haber M; Norris MD; MacKenzie KL; Lock RB
Blood; 2004 May; 103(10):3905-14. PubMed ID: 14764536
[TBL] [Abstract][Full Text] [Related]
5. Quantitative distribution of patient-derived leukemia clones in murine xenografts revealed by cellular barcodes.
Jacobs S; Ausema A; Zwart E; Weersing E; Kingma MJ; El Menshawi YAS; de Haan G; Bystrykh LV; Belderbos ME
Leukemia; 2020 Jun; 34(6):1669-1674. PubMed ID: 31852987
[No Abstract] [Full Text] [Related]
6. Donor-to-Donor Heterogeneity in the Clonal Dynamics of Transplanted Human Cord Blood Stem Cells in Murine Xenografts.
Belderbos ME; Jacobs S; Koster TK; Ausema A; Weersing E; Zwart E; de Haan G; Bystrykh LV
Biol Blood Marrow Transplant; 2020 Jan; 26(1):16-25. PubMed ID: 31494231
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.
Yadav BD; Samuels AL; Wells JE; Sutton R; Venn NC; Bendak K; Anderson D; Marshall GM; Cole CH; Beesley AH; Kees UR; Lock RB
Oncotarget; 2016 Sep; 7(37):58728-42. PubMed ID: 27623214
[TBL] [Abstract][Full Text] [Related]
8. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
Oshima K; Khiabanian H; da Silva-Almeida AC; Tzoneva G; Abate F; Ambesi-Impiombato A; Sanchez-Martin M; Carpenter Z; Penson A; Perez-Garcia A; Eckert C; Nicolas C; Balbin M; Sulis ML; Kato M; Koh K; Paganin M; Basso G; Gastier-Foster JM; Devidas M; Loh ML; Kirschner-Schwabe R; Palomero T; Rabadan R; Ferrando AA
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11306-11311. PubMed ID: 27655895
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice.
Cheung AM; Nguyen LV; Carles A; Beer P; Miller PH; Knapp DJ; Dhillon K; Hirst M; Eaves CJ
Blood; 2013 Oct; 122(18):3129-37. PubMed ID: 24030380
[TBL] [Abstract][Full Text] [Related]
10. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance.
Chiu PP; Jiang H; Dick JE
Blood; 2010 Dec; 116(24):5268-79. PubMed ID: 20810926
[TBL] [Abstract][Full Text] [Related]
11. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
[TBL] [Abstract][Full Text] [Related]
12. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
15. The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse.
Lock RB; Liem N; Farnsworth ML; Milross CG; Xue C; Tajbakhsh M; Haber M; Norris MD; Marshall GM; Rice AM
Blood; 2002 Jun; 99(11):4100-8. PubMed ID: 12010813
[TBL] [Abstract][Full Text] [Related]
16. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
Samuels AL; Beesley AH; Yadav BD; Papa RA; Sutton R; Anderson D; Marshall GM; Cole CH; Kees UR; Lock RB
Blood Cancer J; 2014 Aug; 4(8):e232. PubMed ID: 25083816
[TBL] [Abstract][Full Text] [Related]
17. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
18. Genetic variegation of clonal architecture and propagating cells in leukaemia.
Anderson K; Lutz C; van Delft FW; Bateman CM; Guo Y; Colman SM; Kempski H; Moorman AV; Titley I; Swansbury J; Kearney L; Enver T; Greaves M
Nature; 2011 Jan; 469(7330):356-61. PubMed ID: 21160474
[TBL] [Abstract][Full Text] [Related]
19. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
[TBL] [Abstract][Full Text] [Related]
20. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
Jin B; Wang C; Li J; Du X; Ding K; Pan J
Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
